133 related articles for article (PubMed ID: 19741064)
1. Prospective study to determine the volume of pleural fluid required to diagnose malignancy.
Swiderek J; Morcos S; Donthireddy V; Surapaneni R; Jackson-Thompson V; Schultz L; Kini S; Kvale P
Chest; 2010 Jan; 137(1):68-73. PubMed ID: 19741064
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of the volume of pleural fluid required for accurate diagnosis of malignant pleural effusion.
Abouzgheib W; Bartter T; Dagher H; Pratter M; Klump W
Chest; 2009 Apr; 135(4):999-1001. PubMed ID: 19017891
[TBL] [Abstract][Full Text] [Related]
3. Volume of pleural fluid required for diagnosis of pleural malignancy.
Sallach SM; Sallach JA; Vasquez E; Schultz L; Kvale P
Chest; 2002 Dec; 122(6):1913-7. PubMed ID: 12475826
[TBL] [Abstract][Full Text] [Related]
4. A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: a retrospective analysis of 2540 cases.
Rooper LM; Ali SZ; Olson MT
Cancer Cytopathol; 2014 Sep; 122(9):657-65. PubMed ID: 25060164
[TBL] [Abstract][Full Text] [Related]
5. Limited additive value of pleural fluid carcinoembryonic antigen level in malignant pleural effusion.
Riantawan P; Sangsayan P; Bangpattanasiri K; Rojanaraweewong P
Respiration; 2000; 67(1):24-9. PubMed ID: 10705258
[TBL] [Abstract][Full Text] [Related]
6. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion.
Benlloch S; Galbis-Caravajal JM; Martín C; Sanchez-Paya J; Rodríguez-Paniagua JM; Romero S; Mafe JJ; Massutí B
Cancer; 2006 Oct; 107(8):1859-65. PubMed ID: 16983705
[TBL] [Abstract][Full Text] [Related]
7. A Prospective Study to Evaluate a Diagnostic Algorithm for the Use of Fluid Lymphocyte Subset Analysis in Undiagnosed Unilateral Pleural Effusions.
Dixon G; Bhatnagar R; Zahan-Evans N; Clive AO; Virgo PF; Brett MT; Otton SH; Medford ARL; Maskell NA
Respiration; 2018; 95(2):98-105. PubMed ID: 29131120
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
Ong KC; Indumathi V; Poh WT; Ong YY
Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and characterization of malignant effusions through pleural fluid cytological examination.
Porcel JM
Curr Opin Pulm Med; 2019 Jul; 25(4):362-368. PubMed ID: 31082996
[TBL] [Abstract][Full Text] [Related]
10. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity in pleural effusions: diagnostic significance.
Yang CT; Lee MH; Lan RS; Chen JK
J Clin Oncol; 1998 Feb; 16(2):567-73. PubMed ID: 9469342
[TBL] [Abstract][Full Text] [Related]
12. Value of DNA analysis in addition to cytological testing in the diagnosis of malignant pleural effusions.
Rodríguez de Castro F; Molero T; Acosta O; Julià-Serdà G; Caminero J; Cabrera P; Carrillo T
Thorax; 1994 Jul; 49(7):692-4. PubMed ID: 8066565
[TBL] [Abstract][Full Text] [Related]
13. Reassessing the optimal volume for malignancy detection in serous fluid cytology.
Coconubo DM; Baskota SU; Li R; Srivastava P; Cuda J; Khader S
Cancer Cytopathol; 2022 Jul; 130(7):551-557. PubMed ID: 35468659
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of Initial Thoracentesis for Malignant Pleural Effusion Stratified by Tumor Type in Patients with Strong Evidence of Metastatic Disease.
Grosu HB; Kazzaz F; Vakil E; Molina S; Ost D
Respiration; 2018; 96(4):363-369. PubMed ID: 30016797
[TBL] [Abstract][Full Text] [Related]
15. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R
Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916
[TBL] [Abstract][Full Text] [Related]
16. Screening of malignant pleural effusion by discriminant analysis.
Carrión-Valero F; Perpiñá-Tordera M; Sanchis-Aldás J
Int J Tuberc Lung Dis; 2003 Sep; 7(9):892-8. PubMed ID: 12971675
[TBL] [Abstract][Full Text] [Related]
17. The minimum volume of pleural fluid required to diagnose malignant pleural effusion: A retrospective study.
Wu H; Khosla R; Rohatgi PK; Chauhan SS; Paal E; Chen W
Lung India; 2017; 34(1):34-37. PubMed ID: 28144058
[TBL] [Abstract][Full Text] [Related]
18. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of cholesterol in pleural effusions.
Ram KN; Sing RS
J Assoc Physicians India; 1995 Nov; 43(11):748-50. PubMed ID: 8773031
[TBL] [Abstract][Full Text] [Related]
20. [Thoracoscopy--the method of choice in the determination of a malignancy as the cause of pleural effusion of unknown etiology].
Guska S
Med Arh; 2002; 56(4):213-6. PubMed ID: 12518537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
